Investigation on Etiology of Hepatic Venous Obstruction Budd-Chiari Syndrome

被引:0
作者
Zhi-Long Tian
Gao-Lei Jia
Hai-Lin Xi
Su Feng
Xiao-Kai Wang
Rui Li
机构
[1] Affiliated Hospital of Southeast University,Department of General Surgery, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical College
[2] Affiliated Hospital of Southeast University,Department of Central Laboratory, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical College
来源
Cell Biochemistry and Biophysics | 2014年 / 70卷
关键词
Budd-Chiari syndrome; Hepatic venous occlusion; Intimal proliferation;
D O I
暂无
中图分类号
学科分类号
摘要
Budd-Chiari syndrome (BCS) is an uncommon clinical condition with a complex etiology. Pathogenesis of BCS is still poorly understood. We included hepatic veno-occlusive lesion tissues of 20 patients (patients group) with hepatic venous obstruction BCS and compared with 20 similar tissues with other etiologies (control group). Morphological changes in hepatic veno-occlusive lesion tissues and the positive expression of proliferating cell nuclear antigen (PCNA), C-myc, and P-53 were observed by the pathological examination (H&E staining) and immunohistochemistry assay. Our results showed that PCNA and C-myc positive cell densities were significantly higher in patient group than control group. P-53 positive cell density showed increasing trends in patients than control group. Moreover, we observed irregular hyperplasia in intimal tissue, fibrous connective tissue, and smooth muscle cell, accompanied by tissue degeneration (hyaloid degeneration and fibrinoid degeneration) and a large quantity of inflammatory cell infiltration. In conclusion, an overexpression of PCNA, C-myc, and a weak positive expression of P53 might launch the extremely irregular hepatic venous intimal hyperplasia, which is probably one of the etiologies of hepatic venous obstruction BCS.
引用
收藏
页码:1803 / 1806
页数:3
相关论文
共 42 条
[1]  
Rajani R(2009)Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival—an 18-year experience Liver International 29 253-259
[2]  
Melin T(2007)Budd-Chiari syndrome: Hepatic venous web outflow obstruction treated by percutaneous placement of hepatic vein stent Seminars in Interventional Radiology 24 100-105
[3]  
Bjornsson T(2002)Nodular regenerative hyperplasia of the liver in Budd-Chiari syndrome. CT and MR features Abdominal Imaging 25 255-258
[4]  
Bozorgmanesh A(2001)Budd-Chiari syndrome and extrahepatic portal obstruction associated with congenital antithrombin III deficiency Journal of Gastroenterology 36 341-345
[5]  
Selvam DA(2001)Compound heterozygosity for factor V Leiden and prothrombin G20210A mutations in a child with Budd-Chiari syndrome European Journal of Pediatrics 160 198-14
[6]  
Caridi JG(2003)Relationship between expression of p53, nm23, PCNA and invasion and metastasis of colon carcinoma Guangdong Medical Journal 4 381-536
[7]  
Rha SE(1999)Antisense oligonucleotides inhibit c-myc and PCNA expression in the vascular smooth muscle cells Zhonghua Yi Xue Za Zhi 79 10-111
[8]  
Lee MG(2001)Liver nodules resembling focal nodular hyperplasia Journal of Hepatology 34 781-2090
[9]  
Lee YS(1994)Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-gamma, heparin, and cyclic nucleotide analogues and induces apoptosis Circulation Research 74 525-612
[10]  
Nakase H(1999)Investigation on c-myc and p53 gene expression and proliferation, apoptosis of pulmonary vascular wall cells in chronic hypoxic rats Chinese Journal of Applied Physiology 15 169-undefined